| 1 |
Shin A, Connolly S, Kabytaev K. Protein glycation in diabetes mellitus. Advances in Clinical Chemistry 2023. [DOI: 10.1016/bs.acc.2022.11.003] [Reference Citation Analysis]
|
| 2 |
Schmutzler S, Wölk M, Hoffmann R. Differentiation and Quantitation of Coeluting Isomeric Amadori and Heyns Peptides Using Sugar-Specific Fragment Ion Ratios. Anal Chem 2022. [PMID: 35609340 DOI: 10.1021/acs.analchem.2c00681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Monu, Agnihotri P, Saquib M, Sarkar A, Chakraborty D, Kumar U, Biswas S. Transthyretin and Receptor for Advanced Glycation End Product's Differential Levels Associated with the Pathogenesis of Rheumatoid Arthritis. J Inflamm Res 2021;14:5581-96. [PMID: 34737606 DOI: 10.2147/JIR.S327736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Soboleva A, Vashurina N, Frolov A. Individual Glycation Sites as Biomarkers of Type 2 Diabetes Mellitus. Type 2 Diabetes - From Pathophysiology to Cyber Systems 2021. [DOI: 10.5772/intechopen.95532] [Reference Citation Analysis]
|
| 5 |
Hong J, Xin S, Min R, Zhang Y, Deng Y. The tryptic peptides of hemoglobin for diagnosis of type 2 diabetes mellitus using label-free and standard-free LC-ESI-DMRM. Redox Biol 2021;43:101985. [PMID: 33932868 DOI: 10.1016/j.redox.2021.101985] [Reference Citation Analysis]
|
| 6 |
Bayarsaikhan G, Bayarsaikhan D, Oh PC, Kang WC, Lee B. CUPRAC-Reactive Advanced Glycation End Products as Prognostic Markers of Human Acute Myocardial Infarction. Antioxidants (Basel) 2021;10:434. [PMID: 33799852 DOI: 10.3390/antiox10030434] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Li W, Yan D, Jin Y, Li H, Ma M, Wu Z. Application of Mass Spectrometry in Analysis of Non-Enzymatic Glycation Proteins in Diabetic Blood. Chinese Journal of Analytical Chemistry 2019;47:1732-41. [DOI: 10.1016/s1872-2040(19)61197-7] [Reference Citation Analysis]
|
| 8 |
Xu J, Jiang Z, Liu X, Ma Y, Ma W, Ma L. Ultra-performance liquid chromatography-mass spectrometry-based metabolomics reveals Huangqiliuyi decoction attenuates abnormal metabolism as a novel therapeutic opportunity for type 2 diabetes. RSC Adv 2019;9:39858-70. [DOI: 10.1039/c9ra09386a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Spiller S, Blüher M, Hoffmann R. Plasma levels of free fatty acids correlate with type 2 diabetes mellitus. Diabetes Obes Metab 2018;20:2661-9. [PMID: 29943387 DOI: 10.1111/dom.13449] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
|
